• FirefoxInstall the new Firefox »
  •  Dow Up 0.21% Nasdaq Up 0.32%

    CytRx Corporation (CYTR)

    -NasdaqCM
    3.27 Up 0.12(3.81%) Mar 5, 4:00PM EST
    |After Hours : 3.43 Up 0.16 (4.89%) Mar 5, 6:51PM EST
    Add to Portfolio
    Prev Close:3.15
    Open:3.32
    Bid:N/A
    Ask:3.44 x 5000
    1y Target Est:12.00
    Beta:1.26
    Next Earnings Date:N/A
    Day's Range:3.21 - 3.42
    52wk Range:2.08 - 5.67
    Volume:929,687
    Avg Vol (3m):1,341,190
    Market Cap:182.26M
    P/E (ttm):N/A
    EPS (ttm):-0.87
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYTR

    Comparison

    Symbol% ChgMkt Cap
    CYTRUp 3.81%182.26M
    LLYDown 0.08%74.87B
    NVSDown 0.09%237.34B
    SNYUp 0.04%127.26B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,755.68
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.72
    Quarterly EPS Est (Dec-14) :-0.27
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate includes aldoxorubicin that has completed Phase IIb clinical trial as a first-line therapy for soft t... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback